SML3861
Methoxy-X04
≥98% (HPLC), Aβ fluorescent probe, powder
Synonym(s):
4,4′-(1E,1′E)-2,2′-(2-Methoxy-1,4-phenylene)bis(ethene-2,1-diyl)diphenol, 4,4′-[(2-Methoxy-1,4-phenylene)di-(1E)-2,1-ethenediyl]bisphenol, MX04, MXO4, MeO-X04, MeO-XO4, MeX04, MeXO4, Methoxy-XO4, MethoxyX04, MethoxyXO4
Sign In to View Organizational & Contract Pricing
Select a Size
About This Item
Empirical Formula (Hill Notation):
C23H20O3
CAS Number:
Molecular Weight:
344.40
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.77
Product Name
Methoxy-X04, ≥98% (HPLC)
Quality Level
Assay
≥98% (HPLC)
form
powder
color
, Faint yellow to dark orange
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Related Categories
Biochem/physiol Actions
A blood-brain barrier-permeant probe for live amyloid plaques imaging by fluorescent 2-photon microscopy.
Methoxy-X04 (MeO-X04, MethoxyX04, MeX04, MX04) is a blood-brain barrier-permeant fluorescent probe derived from the Chrysamine G and Congo red scaffold that retains affinity toward amyloid beta (Aβ) fibrils (Ki = 25.3 nM/Chrysamine G and 26.8 nM/Methoxy-X04), while being much more lipophilic than Chrysamine G and Congo red. Methoxy-X04 stains Aβ plaques, tangles, and cerebrovascular amyloid in postmortem brain sections with good specificity and is commonly utilized for high-resolution fluorescent imaging of individual amyloid plaques in live animals by 2-photon microscopy (Ex. 750-800 nm; Em. 380-480, 500-540, and 560-650 nm) following i.v. or i.p. injection (5-10 mg/kg).
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease
The Journal of Neuroscience, 26(2), 365-371 (2006)
William E Klunk et al.
Journal of neuropathology and experimental neurology, 61(9), 797-805 (2002-09-17)
The identification of amyloid deposits in living Alzheimer disease (AD) patients is important for both early diagnosis and for monitoring the efficacy of newly developed anti-amyloid therapies. Methoxy-X04 is a derivative of Congo red and Chrysamine-G that contains no acid
Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding A? plaques by iGluSnFR two-photon imaging
Nature Communications, 7, 13441-13441 (2016)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service